Axia Orthopedics Marks Clinical Debut of SOLOFIX™ with First Surgical Cases
PORTLAND, Ore. — September 16, 2026 — Axia Orthopedics, medical device company that develops surgeon-driven provisional fixation technologies, announces first clinical use of the SOLOFIX™ Provisional Fixation System, marking the commercial launch of the company’s flagship technology for provisional fixation in fracture and arthrodesis surgery.
Dr. Anjan Shah, an orthopedic trauma surgeon at Florida Orthopaedic Institute, used SOLOFIX during two procedures at Tampa General Hospital, with support from trauma fellows Dr. Joshua Sun and Dr. Luke DiPasquale. The procedures included an open reduction and internal fixation of a bimalleolar ankle fracture and a revision correction of a pilon fracture malunion.
SOLOFIX was used to align and compress the lateral and medial ankle fractures as well as reduce and compress the lateral fibula plate. SOLOFIX applied one-sided percutaneous implant compression during the pilon revision. Its use across an acute fracture and a complex revision illustrates the range of applications the system was designed to support.
“These first cases are an important milestone for Axia, but they are also the beginning of our effort to learn from every use and refine how we deliver value to surgeons, patients, and hospitals,” said Andy Seykora, CEO of Axia Orthopedics. “We are incredibly grateful to Dr. Shah, Dr. Sun, Dr. DiPasquale, and the entire clinical team for helping bring SOLOFIX into the operating room for the first time.”
SOLOFIX is a K-wire-based provisional fixation system designed to simplify how surgeons achieve and maintain reduction and compression during fracture fixation and fusion procedures. The system applies percutaneous axial compression from one side of the surgical site and maintains that compression hands-free, reducing reliance on handheld clamps while helping preserve access and visibility during implant positioning and definitive fixation.
“For years, surgeons have told us that achieving and maintaining reduction is one of the most clinically critical and technically demanding steps in fracture fixation and arthrodesis,” said Seykora. “SOLOFIX was designed hand in hand with surgeons to provide greater precision and control, support less invasive care for patients, and enable more efficient, reliable workflows for healthcare facilities.
About Axia Orthopedics
Axia Orthopedics is a medical device company focused on advancing fracture reduction. Founded in Portland, Oregon, Axia designs surgeon-driven devices and instrumentation that address longstanding challenges in reduction and provisional fixation during fracture and arthrodesis surgery.
By translating direct clinical input into precision-engineered instrumentation, Axia seeks to give surgeons greater control, support less invasive care for patients, and enable more efficient, reliable workflows for healthcare facilities. The company’s flagship product, the SOLOFIX™ Provisional Fixation System, applies one-sided axial compression over a K-wire and maintains compression hands-free while definitive fixation is completed.
To learn more, visit axiaortho.com.
__________________________
Media Contact
Axia Orthopedics
